CRNX - Financial Reports List - Crinetics Pharmaceuticals, Inc. - IntrinsicAlpha

Crinetics Pharmaceuticals, Inc. CRNX

Healthcare - Biotechnology - NASDAQ - US

$ 31.27

-0.888 %

$ 2.91 B

Market Cap

-8.17

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-34.11%	-51.21%
Annual Report	FY	10-K	2024-12-31	-74.11%	-39.10%	-52.22%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-33.71%	-48.87%
Quarterly Report	Q2	8-K	2024-06-30	-59.62%	-45.27%	-56.21%
Quarterly Report	Q1	8-K	2024-03-31	-76.11%	-52.07%	-54.59%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-41.65%	-31.76%
Annual Report	FY	10-K	2023-12-31	-15.28%	-34.12%	-32.60%
Quarterly Report	Q3	8-K	2023-09-30	-24.45%	-42.24%	-35.72%
Quarterly Report	Q2	8-K	2023-06-30	125.06%	-22.24%	-23.12%
Quarterly Report	Q1	8-K	2023-03-31	-14.44%	-24.23%	-41.83%

1